Last quarter (Q4 2023), AC Immune SA's total revenue was CHF―, a decrease of ― from the same quarter last year. In Q4, AC Immune SA's net income was CHF―. See AC Immune SA’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	CHF 3.93M	CHF 14.80M	CHF 3.94M	-	CHF 15.43M	CHF 110.46M
Cost of Revenue	-	-	CHF -74.78M	-	-	-
Gross Profit	-	CHF 14.80M	CHF 3.94M	-	-	-
Operating Expense	CHF 37.26M	CHF 68.60M	CHF 76.10M	CHF 80.20M	CHF 76.69M	CHF 65.92M
Operating Income	CHF -33.32M	CHF -53.80M	CHF -72.17M	CHF -80.20M	CHF -61.26M	CHF 44.54M
Net Non Operating Interest Income Expense	CHF -192.00K	CHF 1.04M	CHF 69.00K	CHF 6.50M	CHF -106.00K	CHF -1.62M
Other Income Expense	CHF 362.00K	-	CHF -1.34M	CHF -601.00K	CHF -555.00K	CHF 2.53M
Pretax Income	CHF -33.15M	CHF -54.22M	CHF -70.74M	CHF -72.99M	CHF -61.92M	CHF 45.44M
Tax Provision	CHF 7.00K	CHF 10.00K	CHF 13.00K	CHF 3.00K	CHF 0.00	CHF 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	CHF -33.16M	CHF -54.23M	CHF -70.73M	CHF -72.99M	CHF -61.92M	CHF 45.44M
Basic EPS	CHF -0.39	CHF -0.64	CHF -0.85	CHF -0.97	CHF -0.86	CHF 0.64
Diluted EPS	CHF -0.39	CHF -0.64	CHF -0.85	CHF -0.97	CHF -0.86	CHF 0.64
Basic Average Shares	CHF 168.05M	CHF 84.69M	CHF 83.55M	CHF 75.25M	CHF 71.90M	CHF 70.60M
Diluted Average Shares	CHF 168.05M	CHF 84.69M	CHF 83.21M	CHF 75.25M	CHF 71.90M	CHF 71.10M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	CHF -0.23	-	-	-	CHF -0.79	CHF 0.65
Reported Normalized Diluted E P S	CHF -0.23	-	-	-	CHF -0.79	CHF 0.64
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	CHF 37.26M	CHF 68.60M	CHF 1.32M	CHF 80.20M	CHF 76.69M	CHF 65.92M
Net Income From Continuing And Discontinued Operation	CHF -33.16M	CHF -54.23M	CHF -70.73M	CHF -72.99M	CHF -61.92M	CHF 45.44M
Normalized Income	CHF -33.38M	-	-	-	CHF -61.37M	CHF 42.91M
Interest Expense	CHF 203.00K	-	-	-	CHF 184.00K	CHF 1.93M
EBIT	CHF -32.95M	-	CHF -70.74M	CHF -72.99M	CHF -61.74M	CHF 47.37M
EBITDA	CHF -31.80M	-	CHF -68.95M	CHF -71.10M	CHF -59.77M	CHF 49.06M

Currency in CHF

AC Immune SA Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing